Search details
1.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37142371
2.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Article
in English
| MEDLINE | ID: mdl-35411939
3.
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer.
Prostate
; 81(13): 992-1001, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34254334
4.
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.
BJU Int
; 123 Suppl 5: 27-35, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30712320
5.
Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer.
BJU Int
; 124 Suppl 1: 50-56, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31090242
6.
Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature.
Support Care Cancer
; 27(2): 373-382, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30350189
7.
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells.
BJU Int
; 121(6): 971-978, 2018 06.
Article
in English
| MEDLINE | ID: mdl-28977728
8.
Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics.
Cancer Metastasis Rev
; 33(2-3): 555-66, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24452758
9.
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients.
Br J Cancer
; 113(8): 1225-33, 2015 Oct 20.
Article
in English
| MEDLINE | ID: mdl-26379078
10.
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.
Cancer
; 120(21): 3346-52, 2014 Nov 01.
Article
in English
| MEDLINE | ID: mdl-24995769
11.
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
J Clin Oncol
; 42(3): 312-323, 2024 Jan 20.
Article
in English
| MEDLINE | ID: mdl-37931206
12.
Clinical need for standardised multidisciplinary meeting assessment processes.
Intern Med J
; 48(2): 230-231, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29415353
13.
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.
Eur Urol
; 81(3): 253-262, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34493414
14.
Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer - an Australian multi-centre observational study.
Eur J Cancer
; 157: 485-492, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34344533
15.
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate Cancer.
Eur Urol Focus
; 7(6): 1287-1291, 2021 11.
Article
in English
| MEDLINE | ID: mdl-32739405
16.
Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer.
Eur Urol Focus
; 7(1): 63-70, 2021 01.
Article
in English
| MEDLINE | ID: mdl-31103601
17.
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.
Mol Cancer Ther
; 20(11): 2140-2150, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34413130
18.
Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer.
Transl Androl Urol
; 10(4): 1688-1699, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33968657
19.
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.
Nat Commun
; 12(1): 5049, 2021 08 19.
Article
in English
| MEDLINE | ID: mdl-34413304
20.
PARP inhibitor combinations in prostate cancer.
Ther Adv Med Oncol
; 12: 1758835919897537, 2020.
Article
in English
| MEDLINE | ID: mdl-32215055